120 related articles for article (PubMed ID: 6172230)
1. Diamminodichloride platinum (cis-platinum) in the treatment of hepatocellular carcinoma.
Melia WM; Westaby D; Williams R
Clin Oncol; 1981 Dec; 7(4):275-80. PubMed ID: 6172230
[No Abstract] [Full Text] [Related]
2. Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center.
Abrams RA; Pajak TF; Haulk TL; Flam M; Asbell SO
Cancer J Sci Am; 1998; 4(3):178-84. PubMed ID: 9612600
[TBL] [Abstract][Full Text] [Related]
3. [Hepatocellular carcinoma with cirrhosis: treatment with doxorubicin. Phase II evaluation].
Barbare JC; Ballet F; Petit J; Poupon R; Darnis F
Bull Cancer; 1984; 71(5):442-5. PubMed ID: 6084528
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy after liver transplantation for hepatocellular carcinoma.
Rizzi PM; Ryder SD; Ramage JK; Gane E; Karani J; Heaton N; Portmann B; Tan KC; Williams R
Transplant Proc; 1994 Dec; 26(6):3568-9. PubMed ID: 7527979
[No Abstract] [Full Text] [Related]
5. Continuous-infusion doxorubicin in the treatment of primary hepatic malignancies of childhood.
Neglia JP; Woods WG
Cancer Treat Rep; 1986 May; 70(5):655-7. PubMed ID: 2423238
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of granisetron as anti-emetic agent for emesis induced by intra-arterial injection therapy for hepatocellular carcinoma].
Ichida T; Isokawa O; Itoh S; Ohta H; Takagi K; Hatakeyama S; Tsuruya T; Doya Y; Nozawa A; Hata K; Hara H; Hirose S; Watanabe T; Asakura H
Gan To Kagaku Ryoho; 1998 Oct; 25(12):1939-46. PubMed ID: 9797817
[TBL] [Abstract][Full Text] [Related]
7. [Intra-arterial infusion chemotherapy of cisplatin (CDDP)-lipiodol suspension using implantable injection port for unresectable liver cancer patients].
Aogi K; Sawamura A; Funakoshi M; Toge T
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1485-8. PubMed ID: 7690535
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of high-dose 4'epidoxorubicin in hepatocellular carcinoma.
Shiu W; Leung N; Li M; Leung WT; Li AK
Jpn J Clin Oncol; 1988 Sep; 18(3):235-7. PubMed ID: 2842522
[TBL] [Abstract][Full Text] [Related]
9. [Regression of hepatocellular carcinoma under Tamoxifen: report of one case and review of the literature].
Macaigne G; Auriault ML; Boivin JF; Cheaib S; Chayette C; Deplus R
Gastroenterol Clin Biol; 2002 Dec; 26(12):1165-7. PubMed ID: 12520204
[TBL] [Abstract][Full Text] [Related]
10. [A case of advanced hepatocellular carcinoma responding to suppository of Tegafur].
Kudo K; Arakawa A; Takagi Y; Nishimura R; Yamashita Y; Takahashi M
Gan To Kagaku Ryoho; 1998 Apr; 25(5):747-50. PubMed ID: 9571975
[TBL] [Abstract][Full Text] [Related]
11. The influence of the time of administration on cis-platinum induced nausea and vomiting.
Moore JM
Oncol Nurs Forum; 1982; 9(3):26-32. PubMed ID: 6921790
[No Abstract] [Full Text] [Related]
12. Embryo extracts opotherapy reduces alpha-fetoprotein levels in hepatocellular carcinoma patients.
Franchi F; Ielapi T; Bizzarri M; Seminara P
J Gastroenterol Hepatol; 2005 Sep; 20(9):1467-8. PubMed ID: 16105144
[No Abstract] [Full Text] [Related]
13. Combination chemotherapy with continuous 5-fluorouracil and low-dose cisplatin infusion for advanced hepatocellular carcinoma.
Tanioka H; Tsuji A; Morita S; Horimi T; Takamatsu M; Shirasaka T; Mizushima T; Ochi K; Kiura K; Tanimoto M
Anticancer Res; 2003; 23(2C):1891-7. PubMed ID: 12820474
[TBL] [Abstract][Full Text] [Related]
14. A phase 2 study of cisplatin in patients with hepatocellular carcinoma.
Okada S; Okazaki N; Nose H; Shimada Y; Yoshimori M; Aoki K
Oncology; 1993; 50(1):22-6. PubMed ID: 7678453
[TBL] [Abstract][Full Text] [Related]
15. [Alpha fetoprotein in hepatocarcinoma].
Segura JM; Pérez-Jiménez F; De Dios J; Cerezo E; Muro J
Rev Clin Esp; 1977 Oct; 147(1):73-5. PubMed ID: 73206
[No Abstract] [Full Text] [Related]
16. [Investigating the alpha-1-fetoprotein in the blood stream of patients with primary hepatocellular carcinoma in the course of chemotherapy (author's transl)].
Zizkovský V; Kordac V; Masek Z; Stĕpán J; Korcáková J; Blahníková L
Cesk Gastroenterol Vyz; 1980 Oct; 34(7):465-73. PubMed ID: 6160917
[No Abstract] [Full Text] [Related]
17. [The effect of etoposide (Et) on primary hepatocellular carcinoma].
Tanaka N; Furusawa A; Shimoda A; Hirai N; Unoura M; Kato Y; Kobayashi K; Izumi R; Matsui O; Hattori N
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2583-5. PubMed ID: 3039924
[No Abstract] [Full Text] [Related]
18. Alpha-fetoprotein and hepatocellular carcinoma.
Colli A; Fraquelli M; Conte D
Am J Gastroenterol; 2006 Aug; 101(8):1939; author reply 1940-1. PubMed ID: 16928257
[No Abstract] [Full Text] [Related]
19. Hepatocellular carcinoma.
Kew MC
Postgrad Med J; 1983; 59 Suppl 4():78-87. PubMed ID: 6196769
[No Abstract] [Full Text] [Related]
20. Serum alpha-fetoprotein response as a surrogate for clinical outcome in patients receiving systemic therapy for advanced hepatocellular carcinoma.
Vora SR; Zheng H; Stadler ZK; Fuchs CS; Zhu AX
Oncologist; 2009 Jul; 14(7):717-25. PubMed ID: 19581525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
